Discover key insights from NeurAxis' Q3 2025 earnings call—revenue growth, commercialization strategy, and outlook ahead of the new CPT code in 2026.

New CPT code changes for invasive cardiology and interventional radiology will take effect on January 1, 2026, impacting a significant portion of hospital net revenue and threatening to exacerbate ...

STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

And except as required by law, STRATA Skin Sciences disclaims any obligation to publicly update or revise any information to ...

Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion ...

Aetna is once again trying to require adherence codes G8851, G8854 and G8855 for reimbursement for CPAP devices or supplies, the Midwest Association for Medical Equipment Services & Suppliers (MAMES) ...

Opening South County Hospital's spreadsheet, the hernia code is easier to find, as there's only one entry instead of an entry ...

First full post acquisition quarter builds momentum for 2026 (Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previou ...

CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 976102026 rates for physician offices, home visits, ...

Discover key insights from Sensus Healthcare’s Q3 2025 earnings call—learn how new CMS codes boost SRT adoption and future growth.

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...